Publication | Closed Access
Rituximab in refractory and non‐refractory myasthenia: A retrospective multicenter study
75
Citations
12
References
2012
Year
RTX is efficacious and well-tolerated. Its use allows for dose reduction or withdrawal of corticosteroids.
| Year | Citations | |
|---|---|---|
Page 1
Page 1